| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/29/1999 | WO1999020745A1 Enteric coated microgranules for stabilizing lactic acid bacteria |
| 04/29/1999 | WO1999020710A1 Process for preparing gel with calcium salts of organic acids |
| 04/29/1999 | WO1999020614A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/29/1999 | WO1999020305A1 Veterinary vaccines |
| 04/29/1999 | WO1999020301A1 Tumour vaccine |
| 04/29/1999 | WO1999020296A1 Oral cyclosporin formulations |
| 04/29/1999 | WO1999020289A1 Clear herbal extract solutions |
| 04/29/1999 | WO1999020285A1 Gel preparations containing polystyrenesulfonate |
| 04/29/1999 | WO1999020283A1 Intra-cancer-cell nuclease activator |
| 04/29/1999 | WO1999020282A1 Progestin therapy with controlled bleeding |
| 04/29/1999 | WO1999020277A1 Rapidly soluble drug composition |
| 04/29/1999 | WO1999020266A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 04/29/1999 | WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 04/29/1999 | WO1999020258A1 Polymers containing antimicrobial agents and methods for making and using same |
| 04/29/1999 | WO1999020256A2 Medicament excipient particles for tissue-specific application of a medicament |
| 04/29/1999 | WO1999020255A1 Oral morphine multiparticulate formulation |
| 04/29/1999 | WO1999020254A1 Novel method for obtaining microspheres and resulting products |
| 04/29/1999 | WO1999020253A1 Encapsulation method |
| 04/29/1999 | WO1999020252A1 Particles |
| 04/29/1999 | WO1999020251A1 Use of inhaled no as anti-inflammatory agent |
| 04/29/1999 | WO1999020250A1 Topical antifungal composition |
| 04/29/1999 | WO1999020249A1 Solution for peritoneal dialysis and process for its manufacture |
| 04/29/1999 | WO1999020248A1 Delivery system for allergy medication via the nasal vestibules |
| 04/29/1999 | WO1999020247A1 Gel preparation containing polystyrene-sulfonates |
| 04/29/1999 | WO1999020246A1 Effervescent base |
| 04/29/1999 | WO1999020245A1 Marker for intestinal diagnosis and intestinal therapy |
| 04/29/1999 | WO1999020244A2 Method for transdermal application of active substances at high, constant dosis |
| 04/29/1999 | WO1999020232A1 Cosmetic formulations for the prevention and therapy of hair loss |
| 04/29/1999 | WO1999020107A1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
| 04/29/1999 | WO1999020098A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients |
| 04/29/1999 | WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 04/29/1999 | WO1999006046A9 Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia |
| 04/29/1999 | WO1999006026A9 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 04/29/1999 | WO1999003452A9 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/29/1999 | DE19747261A1 Single-chamber osmotic pharmaceutical release system |
| 04/29/1999 | DE19733269A1 Production of anhydrous composition containing polar or nonpolar compound |
| 04/29/1999 | CA2649671A1 Progestin therapy for causing endometrial atrophy while maintaining amenorrhea |
| 04/29/1999 | CA2558783A1 Oral morphine multiparticulate formulation |
| 04/29/1999 | CA2308588A1 Polymers containing antimicrobial agents and methods for making and using same |
| 04/29/1999 | CA2308236A1 Medicament excipient particles for tissue-specific application of a medicament |
| 04/29/1999 | CA2308030A1 Delivery system for allergy medication via the nasal vestibules |
| 04/29/1999 | CA2307639A1 Tumour vaccine |
| 04/29/1999 | CA2307615A1 Progestin therapy with controlled bleeding |
| 04/29/1999 | CA2306972A1 Particles |
| 04/29/1999 | CA2306957A1 Method for preparing gel with calcium salt of organic acids |
| 04/29/1999 | CA2306633A1 Effervescent base |
| 04/29/1999 | CA2306085A1 Intra-cancer-cell nuclease activator |
| 04/29/1999 | CA2287485A1 Novel method for obtaining microspheres and resulting products |
| 04/29/1999 | CA2275773A1 Oral cyclosporin formulations |
| 04/28/1999 | EP0911039A2 Drug-resin complexes stabilized by chelating agents |
| 04/28/1999 | EP0911038A1 Anhydrous composition comprising lactulose |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0911032A1 Effervescent compositions containing plant extracts |
| 04/28/1999 | EP0911025A1 Intra-articular preparation for the treatment of arthropathy |
| 04/28/1999 | EP0911024A2 Use of water-soluble or water-dispersible polyurethans as coating agents or binders for pharmaceutical administration forms |
| 04/28/1999 | EP0911023A1 Pharmaceutical or cosmetic compositions containing photosensitizing substances |
| 04/28/1999 | EP0910647A1 Human dnase i hyperactive variants |
| 04/28/1999 | EP0910634A2 ANTISENSE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEgF/VPF) EXPRESSION |
| 04/28/1999 | EP0910576A2 Fusogenic liposomes |
| 04/28/1999 | EP0910413A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
| 04/28/1999 | EP0910412A1 Hydrolysable hydrogels for controlled release |
| 04/28/1999 | EP0910411A1 Hydrophobic preparations containing medium chain monoglycerides |
| 04/28/1999 | EP0910410A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 04/28/1999 | EP0910402A1 Insulin preparations containing carbohydrates |
| 04/28/1999 | EP0910399A1 Stable pharmaceutical composition of bdnf |
| 04/28/1999 | EP0910390A1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer |
| 04/28/1999 | EP0910379A1 Plaster for the transdermal application of pergolide |
| 04/28/1999 | EP0910377A1 Anti-vaginitis composition for topical use comprising one or more anti-vaginitis medicaments and one or more local anaesthetics |
| 04/28/1999 | EP0910375A1 A composition of enalapril and losartan |
| 04/28/1999 | EP0910364A1 Buffered compositions containing a local anaesthetic and used as an anti-inflammatory |
| 04/28/1999 | EP0910353A1 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 04/28/1999 | EP0910352A2 Nonocclusive drug delivery device and process for its manufacture |
| 04/28/1999 | EP0910351A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 04/28/1999 | EP0910350A1 Stabilization of sol-gel derived silica-based glass |
| 04/28/1999 | EP0910349A2 Controlled release tablet |
| 04/28/1999 | EP0910348A1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 04/28/1999 | EP0910347A2 Delivery device |
| 04/28/1999 | EP0910346A2 Marking rapidly disintegrating dosage forms |
| 04/28/1999 | EP0910345A1 Biconvex rapidly disintegrating dosage forms |
| 04/28/1999 | EP0910344A1 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
| 04/28/1999 | EP0910343A1 Emulsion formulations for hydrophilic active agents |
| 04/28/1999 | EP0910342A1 Temperature sensitive gel for sustained delivery of protein drugs |
| 04/28/1999 | EP0910341A1 Pharmaceutical composition to be administered orally |
| 04/28/1999 | EP0910339A2 Buccal polar spray or capsule |
| 04/28/1999 | EP0910308A1 Implant assembly |
| 04/28/1999 | EP0741765B1 Use of bicontinuous microemulsions as pressure sensitive adhesives |
| 04/28/1999 | EP0691886B1 Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same |
| 04/28/1999 | EP0650359B1 Transdermal therapeutic system containing the active substance 17- -oestradiol (anhydrous) |
| 04/28/1999 | EP0641190B1 Oral hygiene composition |
| 04/28/1999 | EP0295248B2 Liposome preparation and antibiotic |
| 04/28/1999 | CN2315955Y Quick-acting rhinitis plug |
| 04/28/1999 | CN2315950Y Cap for treating epilepsy |
| 04/28/1999 | CN1215339A 5 'alpha'-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof |
| 04/28/1999 | CN1215331A Injection formulations of avermectins and milbemycins based on castor oil |
| 04/28/1999 | CN1215330A Antiseptic skin care composition and method for making same |
| 04/28/1999 | CN1215322A Process for encapsulation of caplets in a capsule and solid dosage forms obtainlable by such process |
| 04/28/1999 | CN1215309A Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 04/28/1999 | CN1215084A Productive technology for A type botulism crystalline toxin and frozen-dried protective liquid needed for producing said toxin |
| 04/28/1999 | CN1214938A Frozen dried heptitis A toxicity-reduced bio-vaccine and protective agent thereof |
| 04/28/1999 | CN1214928A Pure natural biological nutrient liquid |